“The National Institute of Neurological Disorders and Stroke Epilepsy Common Data Element Updates: Seizure Severity and Diagnostic Recommendations”, in The National Institute of Neurological Disorders and Stroke Epilepsy Common Data Element Updates: Seizure Severity and Diagnostic Recommendations., Baltimore, MD, 2019.
, , , “The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes.”, Leuk Lymphoma, vol. 60, no. 13, pp. 3161-3171, 2019.
, “Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.”, Ophthalmology, vol. 126, no. 2, pp. 261-273, 2019.
, “Networks of face-to-face social contacts in Niakhar, Senegal.”, PLoS One, vol. 14, no. 8, p. e0220443, 2019.
, , “No association between sleep apnoea and macular telangiectasia type 2 and its markers of severity and progression: a case-control study and retrospective cohort study.”, Clin Exp Ophthalmol, vol. 47, no. 1, pp. 63-68, 2019.
, “No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No.”, Ophthalmology, vol. 126, no. 11, pp. 1541-1548, 2019.
, “Novel Microbial-Based Immunotherapy Approach for Crohn's Disease.”, Front Med (Lausanne), vol. 6, p. 170, 2019.
, “An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults.”, Vaccine, vol. 37, no. 30, pp. 4222-4230, 2019.
, “One-year Pilot Study on the Effects of Nitisinone on Melanin in Patients with OCA-1B”, JCI Insight, vol. 4, no. 2, 2019.
, “Partnering, Not Enduring: Citizen Science and Research Participation.”, Am J Bioeth, vol. 19, no. 9, pp. 44-45, 2019.
, , “Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study.”, Antimicrob Agents Chemother, vol. 63, no. 4, 2019.
, “A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.”, Vaccine, vol. 37, no. 4, pp. 602-611, 2019.
, “A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.”, Vaccine, vol. 37, no. 43, pp. 6500-6509, 2019.
, “A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.”, Clin Infect Dis, vol. 68, no. 12, pp. 2079-2086, 2019.
, “Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers.”, Antimicrob Agents Chemother, vol. 63, no. 9, 2019.
, “Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.”, J Clin Oncol, vol. 37, no. 5, pp. 367-374, 2019.
, “Population Pharmacokinetics of Doxycycline in Children.”, Antimicrob Agents Chemother, 2019.
, “Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents.”, J Clin Pharmacol, vol. 59, no. 12, pp. 1606-1619, 2019.
, “Prenatal Substance Use and Perceptions of Parent and Partner Use Using the 4P's Plus Screener.”, Matern Child Health J, vol. 23, no. 2, pp. 250-257, 2019.
, “Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.”, Ophthalmology, vol. 126, no. 12, pp. 1659-1666, 2019.
, “Prospective study of gestational diabetes and fatty liver scores 9 to 16 years after pregnancy.”, J Diabetes, vol. 11, no. 11, pp. 895-905, 2019.
,